678 research outputs found
Impact of HPV vaccination with Gardasil® in Switzerland.
Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11-14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes were examined in 18-year-old girls five years later (sub-study 1) and in outpatients participating to cervical cancer screening before and after vaccine implementation (sub-study 2).
For sub-study 1, 3726 females aged 18 in 2013 were invited to fill a questionnaire on personal demographics and HPV risk factors and to provide a self-collected cervicovaginal sample for HPV genotyping and Chlamydia trachomatis PCR. Personal data were evaluated by univariable and multivariable statistics. In sub-study 2, the proportion of the vaccine-type HPV among anogenital HPV was examined with archived genotyping data of 8039 outpatients participating to cervical cancer screening from 1999 till 2015. The yearly evolution of this proportion was evaluated by segmented logistic regression.
690 (18.5%) women participated to sub-study 1 and 327 (8.8%) provided a self-collected sample. Prevalence of Chlamydia trachomatis (4.6%) and demographics confirmed that the subjects were representative of sexually-active Swiss young women. Vaccine (five-year coverage: 77.5%) was preferentially accepted by contraceptive-pill users (P = 0.001) and samples were mainly provided by sexually-active subjects (P < 0.001). The proportion (4%) of the vaccine-type HPV in this population was lower than in sub-study 2 outpatients (n = 849, <26 years old) in the pre-vaccine era (25.7%). The proportion of the high-risk vaccine-type HPV decreased significantly (59%, P = 0.0048) in the outpatients during the post-vaccine era, yet this decrease was restricted to those aged less than 26 years (n = 673, P < 0.0001).
The low proportion of vaccine-type HPV in 18-year-old females and its rapid decrease in young women participating to cervical cancer screening extend the success of HPV vaccination to Switzerland. Our data suggest that cervical cancer screening is now entering a stage of reduced proportion of HPV16 and/or 18 in samples reported positive by cytology. In view of the high likelihood of reduced clinical specificity of cytology, primary screening modalities involving HPV testing and cytology should now be re-evaluated in Switzerland
International expert consensus on electronic nicotine delivery systems and heated tobacco products: a Delphi survey.
To provide a consensus from a panel of international experts about electronic nicotine delivery systems (ENDS) and heated tobacco products (HTP).
Cross-sectional survey.
A Delphi survey was conducted among international experts in tobacco control and smoking cessation. The first part addressed statements or recommendations about ENDS, the second about HTP, both divided into four categories: regulation, sale, use and general issues.
Experts from 15 countries.
Individuals with clinical, public health or research expertise in tobacco control and/or smoking cessation.
268 experts were contacted, 92 (34%) completed the first, 55/92 (60%) the second round. Consensus for ENDS: components of e-liquids, an upper limit of nicotine concentration should be defined; a warning on the lack of evidence in long-term safety and addiction potential should be stated; ENDS should not be regulated as consumer products but either as a new category of nicotine delivery or tobacco products; ENDS should not be sold in general stores but in specialised shops, shops selling tobacco or in pharmacies with restriction on sale to minors; administration of illegal drugs is likely with ENDS. Consensus for HTP: HTP have the same addictive potential as cigarettes; they should be regulated as a tobacco product with similar warning messages as cigarettes; their advertisement should not be allowed. ENDS and HTP use should not be allowed in indoor public places; a specific tax should be implemented for ENDS, taxes on HTP should not be lower than those for cigarettes; use of cigarettes is more likely with both ENDS and HTP (dual use) than quitting smoking.
Experts in tobacco control and/or smoking cessation recommend differential regulation for ENDS and HTP. The results of this survey may be useful for health authorities, decision makers and researchers of the tobacco use and cessation field
Trajectory Analysis for Sport and Video Surveillance
In video surveillance and sports analysis applications, object trajectories offer the possibility of extracting rich information on the underlying behavior of the moving targets. To this end we introduce an extension of Point Distribution Models (PDM) to analyze the object motion in their spatial, temporal and spatiotemporal dimensions. These trajectory models represent object paths as an average trajectory and a set of deformation modes, in the spatial, temporal and spatiotemporal domains. Thus any given motion can be expressed in terms of its modes, which in turn can be ascribed to a particular behavior. The proposed analysis tool has been tested on motion data extracted from a vision system that was tracking radio-guided cars running inside a circuit. This affords an easier interpretation of results, because the shortest lap provides a reference behavior. Besides showing an actual analysis we discuss how to normalize trajectories to have a meaningful analysis
Is AM1.5 applicable in practice? Modelling eight photovoltaic materials with respect to light intensity and two spectra
The performance and modelling of 8 Photovoltaic materials under variable light intensity and spectra
Guide pour l'établissement des plans de prévention et de sécurité des entreprises extérieures: Travaux et prestations de catégorie 2
Ce document a été élaboré par un groupe de travail ST/DI et TIS/GS en collaboration avec un préventeur / consultant de l'APAVE. Il est destiné à servir de guide et de référence pour l'élaboration des plans de prévention au sein de la division ST
Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides
Using monoclonal antibodies directed against defined epitopes of endotoxin core, this study demonstrated that the presentation of lipopolysaccharide (LPS) to antibodies is critical for measuring the specific binding of antibodies to LPS structures. False cross-reactive reactions apparently were observed when free core LPS or lipid A were used as antigens in ELISA, whereas coating with complexes of high-density lipoproteins with core LPS increased both the sensitivity and the specificity of the test compared with coating with free core LPS, so that nonspecific binding of antibodies was largely avoided. Using this technique, it was not possible to find broadly cross-reactive core LPS antibodies after immunization of rabbits and humans with rough mutants of gram-negative bacteria. These observations underscore the need for careful evaluation of the potential for cross-reactivity of antisera and of monoclonal antibodies directed against endotoxin cor
Evaluation of Endothelial Cells Differentiated from Amniotic Fluid-Derived Stem Cells
Amniotic fluid holds great promise as a stem cell source, especially in neonatal applications where autologous
cells can be isolated and used. This study examined chemical-mediated differentiation of amniotic fluid-derived
stem cells (AFSC) into endothelial cells and verified the function of AFSC-derived endothelial cells (AFSC-EC).
AFSC were isolated from amniotic fluid obtained from second trimester amnioreduction as part of therapeutic
intervention from pregnancies affected with twin-twin transfusion syndrome. Undifferentiated AFSC were of
normal karyotype with a subpopulation of cells positive for the embryonic stem cell marker SSEA4, hematopoietic
stem cell marker c-kit, and mesenchymal stem cell markers CD29, CD44, CD73, CD90, and CD105.
Additionally, these cells were negative for the endothelial marker CD31 and hematopoietic differentiation
marker CD45. AFSC were cultured in endothelial growth media with concentrations of vascular endothelial
growth factor (VEGF) ranging from 1 to 100 ng/mL. After 2 weeks, AFSC-EC expressed von Willebrand factor,
endothelial nitric oxide synthase, CD31, VE-cadherin, and VEGF receptor 2. Additionally, the percentage of cells
expressing CD31 was positively correlated with VEGF concentration up to 50 ng/mL, with no increase at higher
concentrations. AFSC-EC showed a decrease in stem cells markers c-kit and SSEA4 and were morphologically
similar to human umbilical vein endothelial cells (HUVEC). In functional assays, AFSC-EC formed networks and
metabolized acetylated low-density lipoprotein, also characteristic of HUVEC. Nitrate levels for AFSC-EC, an
indirect measure of nitric oxide synthesis, were significantly higher than undifferentiated controls and significantly
lower than HUVEC. These results indicate that AFSC can differentiate into functional endothelial-like cells
and may have the potential to provide vascularization for constructs used in regenerative medicine strategies
- …